Armata Pharmaceuticals Inc ARMP:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 01/27/23 EST
3.40quote price arrow down-0.01 (-0.29%)
Volume
31,729
52 week range
0.83 - 5.79
Loading...
  • Open3.40
  • Day High3.56
  • Day Low3.05
  • Prev Close3.41
  • 52 Week High5.79
  • 52 Week High Date04/08/22
  • 52 Week Low0.83
  • 52 Week Low Date12/28/22

Key Stats

  • Market Cap122.892M
  • Shares Out36.14M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change165.32

KEY STATS

  • Open3.40
  • Day High3.56
  • Day Low3.05
  • Prev Close3.41
  • 52 Week High5.79
  • 52 Week High Date04/08/22
  • 52 Week Low0.83
  • 52 Week Low Date12/28/22
  • Market Cap122.892M
  • Shares Out36.14M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change165.32

RATIOS/PROFITABILITY

  • EPS (TTM)-1.03
  • P/E (TTM)-3.31
  • Fwd P/E (NTM)-3.04
  • EBITDA (TTM)-31.714M
  • ROE (TTM)-94.18%
  • Revenue (TTM)5.446M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-599.52%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/15/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Armata Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using bacteriophage-based technology. It has developed care therapies, including the multidrug-resistant or superbug strains of bacteria. The Company is a developer of phage therapeutics, which are positioned to address the growing...
Jules Haimovitz
Independent Chairman of the Board
Brian Varnum Ph.D.
Chief Executive Officer, Director
Erin Butler
Principal Financial and Accounting Officer
Address
4503 Glencoe Ave
Marina Del Rey, CA
90292-6372
United States

Top Peers

SYMBOLLASTCHG%CHG
LVTX
LAVA Therapeutics NV
3.46-0.02-0.57%
FIXX
Homology Medicines Inc
1.50-0.03-1.96%
LYRA
Lyra Therapeutics Inc
2.67-0.03-1.11%
BYSI
Beyondspring Inc
2.53-0.03-1.17%
DARE
Dare Bioscience Inc
1.35-0.01-0.37%